Dr Devaux’s background training is in Biological Sciences, focusing on Biology and Health during a PhD in France and a post-doc in the US. He joined the Luxembourg Institute of Health (LIH) in 2005 and became Head of the Cardiovascular Research Unit in 2017. His main interest is the discovery and validation of novel RNA biomarkers and therapeutic targets of cardiac disease. Since his research is translational and he believes that collaboration can forward this area of research, he founded the Cardiolinc network in 2014 to bring together complementary expertise from clinicians, basic researchers, statisticians, bioinformaticians, systems biologists, and industrials, towards the satisfaction of unmet medical needs. He is currently the chair of the EU-CardioRNA COST Action network which gathers 200 scientists and medical doctors from 36 countries with the common aim to catalyze transcriptomics research in cardiovascular disease.

RNA biomarkers of cardiovascular disease

Precision Public Health 2021 is organized by the Department of Precision Health [DoPH](https://www.lih.lu/page/departments/doph-department-of-population-health-779)from the Luxembourg Institute of Health. This webinar series will reflect on the transition that is currently happening from traditional Population Health to Precision Public Health. Experts from the Department of Precision Health at LIH, together with internationally recognized scientists, will discuss the current state of the art in the field of Precision Public Health, covering complementary topics such as Prevention, Omics for Public Health, Digital Health and Artificial Intelligence and Socioeconomic Inequalities.